Hubble Therapeutics

Hubble Therapeutics is developing a gene therapy platform to treat a rare hereditary eye disease that typically begins causing severe progressive vision loss in infancy. The company's patented gene therapy treats Leber congenital amaurosis, a rare inherited eye disorder, enabling patients to reverse this loss and restore vision with a single treatment.